A recent study published in The Permanente Journal explored the potential benefits of cannabidiol (CBD) for individuals experiencing anxiety and sleep disturbances. <\/p>\n\n\n\n
CBD, a non-psychoactive compound found in cannabis, has garnered attention for its possible therapeutic effects without inducing a “high.” <\/p>\n\n\n\n
The study conducted a retrospective analysis at a psychiatric clinic, focusing on 72 adults with primary concerns of anxiety (47 participants) or poor sleep (25 participants). Participants received CBD alongside their standard treatment, with most administered a daily dose of 25 mg in capsule form. Those with anxiety typically took CBD in the morning, while individuals with sleep issues consumed it in the evening. <\/p>\n\n\n\n
Findings revealed that within the first month, 79.2% of patients reported decreased anxiety levels, and this reduction was sustained over the study period. Sleep improvements were noted in 66.7% of participants during the initial month, though sleep scores varied in subsequent assessments. Overall, CBD was well tolerated, with only a few patients reporting side effects such as mild fatigue or sedation. <\/p>\n\n\n\n
While these preliminary results are promising, the study still emphasises the need for controlled clinical trials to establish definitive evidence of CBD’s efficacy for anxiety-related disorders. <\/p>\n\n\n\n
As interest in CBD continues to grow, further research will be crucial in determining its role and effectiveness in mental health treatment. <\/p>\n\n\n\n